Difference between kulatta gutika with atrovastatin in the treatment of dislipidemia

Comparative Evaluation of Efficacy of Kulattha Gutika with Atorvastatin in the Management of Dyslipidemia (Medoroga)

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/12/038818

Enrollment

Registered

2021-12-21

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients willing to participate in the study Age between 30 to 60 years of either sex Subjects fulfilling the following diagnostic criteria of Dyslipidemia Diagnostic Criteria Serum Total Cholesterol less than or equal to 200 mg per dl and or Serum Triglycerides equal to 150 to 499 mg per dl and or Serum HDL Cholesterol less than 40 mg per dl and or Serum LDL Cholesterol equal to 130 to 189 mg per dl

Exclusion criteria

Exclusion criteria: Pre diagnosed cases of major illness like cardiovascular disorder diabetes mellitus and renal disorders Patients taking the medication like glucocorticoids During pregnancy and lactation period in women

Design outcomes

Primary

Measure	Time frame
To assess efficacy of Kulattha Gutika in Total cholesterol Triglyceride HDL LDL VLDL and BMITimepoint: 45 days	—

Secondary

Measure	Time frame
To study the incidence of dyslipidemia as per prakruti corelation with medo rogaTimepoint: before treatment	—

Countries

India

Contacts

Public ContactDr Sadhana Misar wajpeyi

datta meghe institute of medical sciences

sadhanamisar@gmail.com9763732083

Outcome results